Guidant Omnilink .018
This article was originally published in The Gray Sheet
Executive Summary
Biliary stent system gains FDA market go-ahead for treatment of malignant biliary obstructions. Cleared less than a month after agency sign-off on the firm's Rx Herculink Plus biliary stent system for the same indication, the Omnilink system is an enhanced version of Guidant's Megalink SDS biliary stent system and features added strength, lower profile and thinner (Xcelon) expansion balloon material (1"The Gray Sheet" April 23, 2001, In Brief)